In this issue of Cancer Discovery, Patel and colleagues explore the synergistic lethality of PRC2 inactivation and DNMT inhibition in malignant peripheral nerve sheath tumor cells. Reactivation of retrotranspo-sons under this dual control suggests that the viral mimicry response contributes to enhanced cytotoxicity with potential clinical implications.
CITATION STYLE
Guil, S., & Esteller, M. (2022). PRC2 Loss and DNMT Inhibition Boost Viral Mimicry in Cancer. Cancer Discovery, 12(9), 2020–2022. https://doi.org/10.1158/2159-8290.CD-22-0733
Mendeley helps you to discover research relevant for your work.